These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 17182686)

  • 1. CD8 T-cell recognition of multiple epitopes within specific Gag regions is associated with maintenance of a low steady-state viremia in human immunodeficiency virus type 1-seropositive patients.
    Geldmacher C; Currier JR; Herrmann E; Haule A; Kuta E; McCutchan F; Njovu L; Geis S; Hoffmann O; Maboko L; Williamson C; Birx D; Meyerhans A; Cox J; Hoelscher M
    J Virol; 2007 Mar; 81(5):2440-8. PubMed ID: 17182686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD8+ T cell responses to human immunodeficiency viruses type 2 (HIV-2) and type 1 (HIV-1) gag proteins are distinguishable by magnitude and breadth but not cellular phenotype.
    Gillespie GM; Pinheiro S; Sayeid-Al-Jamee M; Alabi A; Kaye S; Sabally S; Sarge-Njie R; Njai H; Joof K; Jaye A; Whittle H; Rowland-Jones S; Dorrell L
    Eur J Immunol; 2005 May; 35(5):1445-53. PubMed ID: 15832290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA.
    Kiepiela P; Leslie AJ; Honeyborne I; Ramduth D; Thobakgale C; Chetty S; Rathnavalu P; Moore C; Pfafferott KJ; Hilton L; Zimbwa P; Moore S; Allen T; Brander C; Addo MM; Altfeld M; James I; Mallal S; Bunce M; Barber LD; Szinger J; Day C; Klenerman P; Mullins J; Korber B; Coovadia HM; Walker BD; Goulder PJ
    Nature; 2004 Dec; 432(7018):769-75. PubMed ID: 15592417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strong cell-mediated immune responses are associated with the maintenance of low-level viremia in antiretroviral-treated individuals with drug-resistant human immunodeficiency virus type 1.
    Deeks SG; Martin JN; Sinclair E; Harris J; Neilands TB; Maecker HT; Hagos E; Wrin T; Petropoulos CJ; Bredt B; McCune JM
    J Infect Dis; 2004 Jan; 189(2):312-21. PubMed ID: 14722897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human leukocyte antigen-specific polymorphisms in HIV-1 Gag and their association with viral load in chronic untreated infection.
    Brumme ZL; Tao I; Szeto S; Brumme CJ; Carlson JM; Chan D; Kadie C; Frahm N; Brander C; Walker B; Heckerman D; Harrigan PR
    AIDS; 2008 Jul; 22(11):1277-86. PubMed ID: 18580606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Broad cross-clade T-cell responses to gag in individuals infected with human immunodeficiency virus type 1 non-B clades (A to G): importance of HLA anchor residue conservation.
    Geels MJ; Dubey SA; Anderson K; Baan E; Bakker M; Pollakis G; Paxton WA; Shiver JW; Goudsmit J
    J Virol; 2005 Sep; 79(17):11247-58. PubMed ID: 16103177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A high viral burden predicts the loss of CD8 T-cell responses specific for subdominant gag epitopes during chronic human immunodeficiency virus infection.
    Geldmacher C; Gray C; Nason M; Currier JR; Haule A; Njovu L; Geis S; Hoffmann O; Maboko L; Meyerhans A; Cox J; Hoelscher M
    J Virol; 2007 Dec; 81(24):13809-15. PubMed ID: 17898052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus.
    Altfeld M; Allen TM; Yu XG; Johnston MN; Agrawal D; Korber BT; Montefiori DC; O'Connor DH; Davis BT; Lee PK; Maier EL; Harlow J; Goulder PJ; Brander C; Rosenberg ES; Walker BD
    Nature; 2002 Nov; 420(6914):434-9. PubMed ID: 12459786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High responsiveness of HLA-B57-restricted Gag-specific CD8+ T cells in vitro may contribute to the protective effect of HLA-B57 in HIV-infection.
    Jansen CA; Kostense S; Vandenberghe K; Nanlohy NM; De Cuyper IM; Piriou E; Manting EH; Miedema F; van Baarle D
    Eur J Immunol; 2005 Jan; 35(1):150-8. PubMed ID: 15593302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity in HIV suppression by CD8 T cells from HIV controllers: association with Gag-specific CD8 T cell responses.
    Sáez-Cirión A; Sinet M; Shin SY; Urrutia A; Versmisse P; Lacabaratz C; Boufassa F; Avettand-Fènoël V; Rouzioux C; Delfraissy JF; Barré-Sinoussi F; Lambotte O; Venet A; Pancino G;
    J Immunol; 2009 Jun; 182(12):7828-37. PubMed ID: 19494307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the cross-clade and cross-species conservation of HIV-1 Gag-specific CD8 and CD4 T cell responses elicited by a clade B DNA/MVA vaccine in macaques.
    Amara RR; Sharma S; Patel M; Smith JM; Chennareddi L; Herndon JG; Robinson HL
    Virology; 2005 Mar; 334(1):124-33. PubMed ID: 15749128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of viral replication with highly active antiretroviral therapy has no impact on the functional profile of HIV-specific CD8(+) T cells.
    López M; Soriano V; Rallón N; Cascajero A; González-Lahoz J; Benito JM
    Eur J Immunol; 2008 Jun; 38(6):1548-58. PubMed ID: 18421792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of viral control in early HIV-1 infection is temporally associated with sequential escape from CD8+ T cell responses and decrease in HIV-1-specific CD4+ and CD8+ T cell frequencies.
    Oxenius A; Price DA; Trkola A; Edwards C; Gostick E; Zhang HT; Easterbrook PJ; Tun T; Johnson A; Waters A; Holmes EC; Phillips RE
    J Infect Dis; 2004 Aug; 190(4):713-21. PubMed ID: 15272399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunodominance of HIV-1-specific CD8(+) T-cell responses in acute HIV-1 infection: at the crossroads of viral and host genetics.
    Lichterfeld M; Yu XG; Le Gall S; Altfeld M
    Trends Immunol; 2005 Mar; 26(3):166-71. PubMed ID: 15745859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistant immunodominant anti-gag SLYNTVATL responses in HIV-patients with up to 7 years of HAART.
    Zidovec Lepej S; Kosor E; Gagro A; Vince A; Remenar A; Poljak M
    Coll Antropol; 2006 Dec; 30 Suppl 2():33-8. PubMed ID: 17508471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Gag-specific T lymphocyte responses during the early phase of human immunodeficiency virus type 1 infection and lower virus load set point.
    Patke DS; Langan SJ; Carruth LM; Keating SM; Sabundayo BP; Margolick JB; Quinn TC; Bollinger RC
    J Infect Dis; 2002 Oct; 186(8):1177-80. PubMed ID: 12355372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of HIV-1-specific CD8 T-cell responses and their role in loss of viremia in children chronically infected with HIV-1 undergoing highly active antiretroviral therapy.
    Zhang Z; Zhao QX; Fu JL; Yao JX; He Y; Jin L; Wang FS
    Chin Med J (Engl); 2006 Dec; 119(23):1949-57. PubMed ID: 17199938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isotype-switched immunoglobulin G antibodies to HIV Gag proteins may provide alternative or additional immune responses to 'protective' human leukocyte antigen-B alleles in HIV controllers.
    French MA; Center RJ; Wilson KM; Fleyfel I; Fernandez S; Schorcht A; Stratov I; Kramski M; Kent SJ; Kelleher AD
    AIDS; 2013 Feb; 27(4):519-28. PubMed ID: 23364441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmid vaccination of stable HIV-positive subjects on antiviral treatment results in enhanced CD8 T-cell immunity and increased control of viral "blips".
    MacGregor RR; Boyer JD; Ugen KE; Tebas P; Higgins TJ; Baine Y; Ciccarelli RB; Ginsberg RS; Weiner DB
    Vaccine; 2005 Mar; 23(17-18):2066-73. PubMed ID: 15755572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of expansion of epitope-specific T cell responses during primary HIV-1 infection.
    Turnbull EL; Wong M; Wang S; Wei X; Jones NA; Conrod KE; Aldam D; Turner J; Pellegrino P; Keele BF; Williams I; Shaw GM; Borrow P
    J Immunol; 2009 Jun; 182(11):7131-45. PubMed ID: 19454710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.